291 related articles for article (PubMed ID: 8616718)
1. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Friesen C; Herr I; Krammer PH; Debatin KM
Nat Med; 1996 May; 2(5):574-7. PubMed ID: 8616718
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
[TBL] [Abstract][Full Text] [Related]
3. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells.
Friesen C; Fulda S; Debatin KM
Leukemia; 1997 Nov; 11(11):1833-41. PubMed ID: 9369415
[TBL] [Abstract][Full Text] [Related]
4. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
[TBL] [Abstract][Full Text] [Related]
5. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells.
Chlichlia K; Peter ME; Rocha M; Scaffidi C; Bucur M; Krammer PH; Schirrmacher V; Umansky V
Blood; 1998 Jun; 91(11):4311-20. PubMed ID: 9596680
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic drugs and the CD95 pathway.
Friesen C; Fulda S; Debatin KM
Leukemia; 1999 Nov; 13(11):1854-8. PubMed ID: 10557062
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
Müller M; Strand S; Hug H; Heinemann EM; Walczak H; Hofmann WJ; Stremmel W; Krammer PH; Galle PR
J Clin Invest; 1997 Feb; 99(3):403-13. PubMed ID: 9022073
[TBL] [Abstract][Full Text] [Related]
9. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
10. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
11. CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes.
Jeremias I; Stahnke K; Debatin KM
Cancer Immunol Immunother; 2005 Jul; 54(7):655-62. PubMed ID: 15703961
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.
Micheau O; Solary E; Hammann A; Martin F; Dimanche-Boitrel MT
J Natl Cancer Inst; 1997 Jun; 89(11):783-9. PubMed ID: 9182976
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction.
Fellenberg J; Mau H; Nedel S; Ewerbeck V; Debatin KM
J Orthop Res; 2000 Jan; 18(1):10-7. PubMed ID: 10716273
[TBL] [Abstract][Full Text] [Related]
14. Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis.
Schaefer JT; Barthlen W; Schweizer P
J Pediatr Surg; 2000 Mar; 35(3):473-9. PubMed ID: 10726692
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.
Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW
J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression.
Yamana K; Bilim V; Hara N; Kasahara T; Itoi T; Maruyama R; Nishiyama T; Takahashi K; Tomita Y
Br J Cancer; 2005 Sep; 93(5):544-51. PubMed ID: 16091761
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines.
Dirks W; Schöne S; Uphoff C; Quentmeier H; Pradella S; Drexler HG
Br J Haematol; 1997 Mar; 96(3):584-93. PubMed ID: 9054667
[TBL] [Abstract][Full Text] [Related]
19. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
20. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation.
Landowski TH; Shain KH; Oshiro MM; Buyuksal I; Painter JS; Dalton WS
Blood; 1999 Jul; 94(1):265-74. PubMed ID: 10381522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]